How many insider trades does FilingIQ track for ABUS?

FilingIQ tracks 63 Form 4 insider transactions for ABUS (Arbutus Biopharma Corp), covering filings from Aug 26, 2015 onwards. 16 of those are dated within the last 90 days.

Are ABUS insiders net buyers or net sellers?

Across the full Form 4 history for ABUS, 1 transactions (2%) were open-market purchases and 24 (38%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ABUS insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.

How many institutions report holding ABUS?

For the quarter ended Jun 30, 2026, 176 institutional managers reported a ABUS position on SEC Form 13F. Investment managers with discretion over $100 million or more in 13(f) securities, mostly US-listed stocks, file a Form 13F within 45 days of each quarter end.

ABUS insider trading

CIK 1447028

Arbutus Biopharma Corp: insider trade history from SEC Form 4 filings.

Form 4 trades

Last 90 days

Buys / sells

2% / 38%

Insiders

ABUS insider activity at a glance

FilingIQ tracks 63 insider transactions for ABUS in filings since Aug 26, 2015. The most recent transaction is dated Oct 1, 2026. They were reported by 16 insiders.

Across the full history, 1 open-market purchases and 24 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.

Open ABUS on FilingIQ Raw filings on SEC EDGAR

Latest ABUS Form 4 filings

Beardsley Robert A

D Oct 7, 2026

Nguyen Tuan Chief Financial Officer

D Oct 7, 2026

Sawhney Roger

D Oct 7, 2026

Androski Lindsay President and CEO

D Oct 7, 2026

Androski Lindsay President and CEO

FM Sep 23, 2026

Nguyen Tuan Chief Financial Officer

Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.

Tickers with similar insider activity

Ranked next to ABUS by Form 4 lines in the last 90 days, the number on each card.

LUCY 16

Innovative Eyewear Inc

BAER 16

Bridger Aerospace Group Holdings, Inc.

MOBX 16

MOBIX LABS, INC

DSM 16

BNY MELLON STRATEGIC MUNICIPAL BOND FUND, INC.

PSFE 16

Paysafe Ltd

MSGM 16

Motorsport Games Inc.

13F funds holding ABUS

For the quarter ended Jun 30, 2026, 176 institutional managers reported a ABUS position on SEC Form 13F.

Frequently asked

How many insider trades does FilingIQ track for ABUS?: FilingIQ tracks 63 Form 4 insider transactions for ABUS (Arbutus Biopharma Corp), covering filings from Aug 26, 2015 onwards. 16 of those are dated within the last 90 days.
Are ABUS insiders net buyers or net sellers?: Across the full Form 4 history for ABUS, 1 transactions (2%) were open-market purchases and 24 (38%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ABUS insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
How many institutions report holding ABUS?: For the quarter ended Jun 30, 2026, 176 institutional managers reported a ABUS position on SEC Form 13F. Investment managers with discretion over $100 million or more in 13(f) securities, mostly US-listed stocks, file a Form 13F within 45 days of each quarter end.

Methodology & sources

Every ABUS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Institutional holder counts come from the quarter's SEC Form 13F reports. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.